Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gemcitabine hydrochloride and cisplatin with or without nab-paclitaxel in newly diagnosed advanced biliary tract cancers has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Bile Duct Cancer
• Gallbladder Cancer
• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8 | Phase 3 | Status: COMPLETED | Results posted: 2024-10-22